Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 8,526–8,550 of 27,380 studies, newest first · page 342 of 1096.

August 2022 25

  1. 2022-08-30

    Plasma biomarkers and their correlation in adult children of parents with Alzheimer's disease

    ✓ Peer-reviewed Biomarkers Frontiers in aging neuroscience

    Key finding: Family history (FH) of late-onset Alzheimer's disease (AD) is associated with changes in several cerebrospinal fluid (CSF) biomarkers in cognitively normal individuals. +1 more finding

  2. 2022-08-30

    Brain-age is associated with progression to dementia in memory clinic patients

    ✓ Peer-reviewed Cognitive tests and assessment NeuroImage. Clinical

    Key finding: Biomarkers for the early detection of dementia risk hold promise for better disease monitoring and targeted interventions. +3 more findings

  3. 2022-08-29
  4. 2022-08-28

    Influence of genetic and cardiometabolic risk factors in Alzheimer's disease

    ✓ Peer-reviewed Risk factors Ageing research reviews

    Key finding: These potential risk factors associated with cerebral metabolic changes which fuel AD pathogenesis have been suggested to be the reason for the disappointing clinical trial results.

  5. 2022-08-28

    Head-to-Head Comparison of Different Blood Collecting Tubes for Quantification of Alzheimer's Disease Biomarkers in Plasma

    ✓ Peer-reviewed Biomarkers Biomolecules

    Key finding: We found that plasma collected in Li-Hep and Na-Hep tubes yielded significantly higher tau and p-tau181 levels compared to plasma collected in K2-EDTA tubes from the same person, but there was no difference in the measured values of the Aβ40, Aβ42, and Aβ42/40 ratio.

  6. 2022-08-28

    Emerging strategies in targeting tumor-resident myeloid cells for cancer immunotherapy

    ✓ Peer-reviewed TREM2 and immune genetics Journal of hematology & oncology

    Key finding: However, despite over 40% of cancer patients being eligible to receive immunotherapy, only 12% of patients gain benefit. +3 more findings

  7. 2022-08-27

    Documenting the need for teaching resourcefulness skills to family caregivers

    ✓ Peer-reviewed Caregiving Applied nursing research : ANR

    Key finding: Caregivers differed significantly on caregiver burden (F = 2.46; p = .014) and resourcefulness (F = 2.08; p = .038). +4 more findings

  8. 2022-08-27

    Microglial large extracellular vesicles propagate early synaptic dysfunction in Alzheimer's disease

    ✓ Peer-reviewed Disease mechanisms Brain : a journal of neurology

    Key finding: Similar results were obtained upon injection of extracellular vesicles carrying Aβ naturally secreted by CHO7PA2 cells, while neither Aβ42 alone nor inflammatory extracellular vesicles devoid of Aβ were able to propagate long-term potentiation impairment.

  9. 2022-08-27

    Alzheimer's disease, cerebrovascular disease and dementia: lump, split or integrate?

    ✓ Peer-reviewed Vascular contributions Brain : a journal of neurology

    Key finding: This scientific commentary refers to ‘Cerebral amyloid angiopathy interacts with neuritic amyloid plaques to promote tau and cognitive decline’ by Rabin et al.

  10. 2022-08-27

    Unifying framework for cognitive training interventions in brain aging

    ✓ Peer-reviewed Prevention trials Ageing research reviews

    Key finding: Cognitive training is a promising tool for slowing or preventing cognitive decline in older adults at-risk for dementia. +4 more findings

  11. 2022-08-27

    Interactions between apolipoprotein E, sex, and amyloid-beta on cerebrospinal fluid p-tau levels in the European prevention of Alzheimer's dementia longitudinal cohort study (EPAD LCS)

    ✓ Peer-reviewed Tau biomarkers EBioMedicine

    Key finding: The apolipoprotein E (APOE)ε4 allele is the strongest genetic risk factor for late-onset AD and is associated with aberrant cerebrospinal fluid levels (CSF) of total tau (t-tau), phosphorylated tau (p-tau), and amyloid-β (Aβ). +3 more findings

  12. 2022-08-27
  13. 2022-08-26

    Role of Aβ in Alzheimer's-related synaptic dysfunction

    ✓ Peer-reviewed Disease mechanisms Frontiers in cell and developmental biology

    Key finding: Besides, extracellular glutamate accumulation induced by Aβ mediates synapse toxicity resulting from reduced glutamate receptors and glutamate spillovers. +4 more findings

  14. 2022-08-26

    Diet, Gut Microbiome, and Cognitive Decline

    ✓ Peer-reviewed Disease mechanisms Current nutrition reports

    Key finding: An epidemic of age-associated cognitive decline, most commonly ascribed to neurodegenerative conditions such as Alzheimer's and Parkinson's disease, is causing healthcare costs to soar and devastating caregivers. +4 more findings

  15. 2022-08-26

    Progression of Subjective Cognitive Decline to MCI or Dementia in Relation to Biomarkers for Alzheimer Disease: A Meta-analysis

    ✓ Peer-reviewed Tau biomarkers Neurology

    Key finding: The risk of mild cognitive impairment (MCI) or dementia in individuals with subjective cognitive decline (SCD) and biomarkers indicating Alzheimer disease (AD) pathology in comparison with individuals with SCD without biomarker evidence for AD is critical to delineate the potential role of biomarker assessment in this group. +3 more findings

  16. 2022-08-26

    The inter-relationship between delirium and dementia: the importance of delirium prevention

    ✓ Peer-reviewed Prevention and risk Nature reviews. Neurology

    Key finding: People with dementia have a higher risk of developing delirium than the general population, and the occurrence of delirium is an independent risk factor for subsequent development of dementia.

  17. 2022-08-26

    Spatial Navigation and Its Association With Biomarkers and Future Dementia in Memory Clinic Patients Without Dementia

    ✓ Peer-reviewed Biomarkers Neurology

    Key finding: Impaired spatial navigation was associated with conversion to dementia within 2 and 4 years and with key CSF and MRI biomarkers for AD and neurodegeneration in patients with SCD and MCI. +4 more findings

  18. 2022-08-25

    Musical Activity During Life Is Associated With Multi-Domain Cognitive and Brain Benefits in Older Adults

    ✓ Peer-reviewed Prevention trials Frontiers in psychology

    Key finding: Participants reporting having played a musical instrument across three life periods (n = 70) were compared to controls without a history of musical instrument playing (n = 70), well-matched for reserve proxies of education, intelligence, socioeconomic status and physical activity. +1 more finding

  19. 2022-08-25

    Multi-feature computational framework for combined signatures of dementia in underrepresented settings

    ✓ Peer-reviewed Digital health tools Journal of neural engineering

    Key finding: The model accurately identified dementia subtypes using measures readily available in underrepresented settings, with a similar performance than advanced biomarkers. +4 more findings

  20. 2022-08-25

    Microglial Activation and Connectivity in Alzheimer Disease and Aging

    ✓ Peer-reviewed Brain scans and imaging Annals of neurology

    Key finding: Microglial activation distributes preferentially along highly connected brain regions, similar to tau pathology. +4 more findings

  21. 2022-08-24

    Searching for atrial fibrillation: looking harder, looking longer, and in increasingly sophisticated ways. An EHRA position paper

    ✓ Peer-reviewed Cognitive tests and assessment EP Europace

    Key finding: Atrial fibrillation (AF) is the most common clinical arrhythmia with substantial health and socioeconomic impact on healthcare.1 The number of people affected by this condition was estimated to be 33.5 million in 2010, with an increasing prevalence and incidence over the coming years.2 In 2017, there were 37.6 million [95% confidence interval (CI): 32.5–42.6 million] individuals with AF/atrial flutter globally.3 The estimated number of subjects with AF in 2030 in Europe will be 14–17 million, and the number of new cases of AF per year at 120 000–215 000.4 Atrial fibrillation is independently associated with increased mortality and morbidity from complications such as ischaemic stroke, dementia, and cognitive dysfunction.5 Oral anticoagulation can significantly reduce the risk of stroke, dementia, and death.6 As a part of a holistic or integrated approach to AF care, it is associated with improved outcomes7–9 and is advocated in guidelines.10,11 In many patients, AF can be asymptomatic, and the diagnosis is established after the appearance of a complication typically associated with AF, such as ischaemic stroke/systemic embolic or heart failure. +4 more findings

  22. 2022-08-24

    Anti-Inflammatory Effects of GLP-1 Receptor Activation in the Brain in Neurodegenerative Diseases

    ✓ Peer-reviewed Drug development International journal of molecular sciences

    Key finding: These findings update our knowledge of the potential benefits of GLP-1RAS actions in reducing the inflammatory response.

  23. 2022-08-24

    Atypical Alzheimer's disease phenotypes with normal or borderline PET biomarker profiles

    ✓ Peer-reviewed Brain scans and imaging Journal of neurology

    Key finding: Global Aβ and tau-PET standardized uptake value ratios (SUVRs) were plotted for all patients and outliers, and patients with abnormally low SUVRs compared to the biomarker-classic cohort were identified. +1 more finding

  24. 2022-08-24

    Microglial TYROBP/DAP12 in Alzheimer's disease: Transduction of physiological and pathological signals across TREM2

    ✓ Peer-reviewed TREM2 and immune genetics Molecular neurodegeneration

    Key finding: TYROBP is expressed in numerous cell types, including peripheral blood monocytes, macrophages, dendritic cells, and osteoclasts, but a key point of recent interest is related to the critical role played by TYROBP in the function of many receptors expressed on the plasma membrane of microglia. +3 more findings

  25. 2022-08-23

    Validation of the Computerized Cognitive Assessment Test: NNCT

    ✓ Peer-reviewed Cognitive tests and assessment International journal of environmental research and public health

    Key finding: This test aims to digitize cognitive assessments to add greater accessibility than classic tests, as well as to present results in real time and reduce costs. +2 more findings

Browse the library by subject, with the full score breakdown →